These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 18573816

  • 1. Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica.
    Weinstock-Guttman B, Miller C, Yeh E, Stosic M, Umhauer M, Batra N, Munschauer F, Zivadinov R, Ramanathan M.
    Mult Scler; 2008 Sep; 14(8):1061-7. PubMed ID: 18573816
    [Abstract] [Full Text] [Related]

  • 2. Neuromyelitis optica IgG status in acute partial transverse myelitis.
    Scott TF, Kassab SL, Pittock SJ.
    Arch Neurol; 2006 Oct; 63(10):1398-400. PubMed ID: 17030654
    [Abstract] [Full Text] [Related]

  • 3. NMO-IgG and Devic's neuromyelitis optica: a French experience.
    Marignier R, De Sèze J, Vukusic S, Durand-Dubief F, Zéphir H, Vermersch P, Cabre P, Cavillon G, Honnorat J, Confavreux C.
    Mult Scler; 2008 May; 14(4):440-5. PubMed ID: 18208892
    [Abstract] [Full Text] [Related]

  • 4. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ.
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [Abstract] [Full Text] [Related]

  • 5. NMO-IgG predicts the outcome of recurrent optic neuritis.
    Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, Weinshenker BG.
    Neurology; 2008 Jun 03; 70(23):2197-200. PubMed ID: 18434643
    [Abstract] [Full Text] [Related]

  • 6. Neuromyelitis optica and non organ-specific autoimmunity.
    Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zéphir H, Moder K, Weinshenker BG.
    Arch Neurol; 2008 Jan 03; 65(1):78-83. PubMed ID: 18195142
    [Abstract] [Full Text] [Related]

  • 7. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
    Banwell B, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A, Weinshenker BG, Lucchinetti CF, Pittock SJ.
    Neurology; 2008 Jan 29; 70(5):344-52. PubMed ID: 18094334
    [Abstract] [Full Text] [Related]

  • 8. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
    Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T, Minohara M, Kikuchi H, Mihara F, Ohyagi Y, Kira J.
    Brain; 2007 May 29; 130(Pt 5):1206-23. PubMed ID: 17439988
    [Abstract] [Full Text] [Related]

  • 9. A case of longitudinally extensive transverse myelitis (LETM): neuromyelitis optica.
    Mangat P, Ravindran J, Cleland L, Limaye V.
    Clin Rheumatol; 2008 Dec 29; 27 Suppl 2():S67-9. PubMed ID: 18560921
    [Abstract] [Full Text] [Related]

  • 10. Seroprevalence of NMO-IgG among patients with neuromyelitis optica and opticospinal multiple sclerosis.
    Etemadifar M, Mollabashi M, Chitsaz A, Behnamfar O, Bahrami E, Minagar A, Maghzi AH.
    Clin Neurol Neurosurg; 2012 Jan 29; 114(1):17-20. PubMed ID: 22014378
    [Abstract] [Full Text] [Related]

  • 11. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis.
    Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA.
    Ann Neurol; 2006 Mar 29; 59(3):566-9. PubMed ID: 16453327
    [Abstract] [Full Text] [Related]

  • 12. Absence of neuromyelitis optica IgG antibody in an active relapsing-remitting multiple sclerosis population.
    Smith CH, Waubant E, Langer-Gould A.
    J Neuroophthalmol; 2009 Jun 29; 29(2):104-6. PubMed ID: 19491632
    [Abstract] [Full Text] [Related]

  • 13. [Neuromyelitis optica: the disease entity, pathogenesis and therapy].
    Fujihara K.
    Rinsho Shinkeigaku; 2007 Nov 29; 47(11):883-5. PubMed ID: 18210826
    [Abstract] [Full Text] [Related]

  • 14. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T, Fujihara K, Itoyama Y.
    Brain Nerve; 2008 May 29; 60(5):527-37. PubMed ID: 18516975
    [Abstract] [Full Text] [Related]

  • 15. Brain abnormalities in neuromyelitis optica.
    Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG.
    Arch Neurol; 2006 Mar 29; 63(3):390-6. PubMed ID: 16533966
    [Abstract] [Full Text] [Related]

  • 16. Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands.
    Nakamura M, Nakashima I, Sato S, Miyazawa I, Fujihara K, Itoyama Y.
    Mult Scler; 2007 Apr 29; 13(3):332-5. PubMed ID: 17439901
    [Abstract] [Full Text] [Related]

  • 17. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
    Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y.
    Brain; 2007 May 29; 130(Pt 5):1235-43. PubMed ID: 17449477
    [Abstract] [Full Text] [Related]

  • 18. Differential regulation of IgG-NMO autoantibodies on S100Beta protein and disability in relapsing neuromyelitis optica.
    Robinson-Agramonte MA, Gonçalves CA, Portela LV, Saiz-Hinarejos A, Oses JP, Motta LS, Muller AP, Marquez Gonzalez ME, Souza DO.
    Neuroimmunomodulation; 2010 May 29; 17(3):177-9. PubMed ID: 20134196
    [Abstract] [Full Text] [Related]

  • 19. Relationship between neuromyelitis optica-IgG status and spinal cord magnetic resonance imaging in patients with neuromyelitis optica.
    Zhong XN, Wang HH, Bao J, Li R, Long YM, Lu ZQ, Dai YQ, Qiu W, Hu XQ.
    Chin Med J (Engl); 2012 Jan 29; 125(2):270-4. PubMed ID: 22340558
    [Abstract] [Full Text] [Related]

  • 20. Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates.
    Eichel R, Meiner Z, Abramsky O, Gotkine M.
    Arch Neurol; 2008 Feb 29; 65(2):267-71. PubMed ID: 18268199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.